Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AZIYO BIOLOGICS, INC. (AZYO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 8-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | 60.9% | 59.9% | 51.8% | 53.9% | |
| Gross profit | 39.1% | 40.1% | 48.2% | 46.1% | |
| Sales and marketing | 41.1% | 39.7% | 41.2% | 37.7% | |
| Research and development | 18.2% | 19.6% | 13.9% | 5.6% | |
| General and administrative | 33.8% | 28.9% | 24.9% | 22.4% | |
| EBITDA | -46.4% | -40.1% | -22.8% | -19.6% | |
| Depreciation | 7.6% | 7.9% | 9.1% | | |
| EBIT | -54.0% | -48.0% | -31.9% | -19.6% | |
| Pre-tax income | -66.8% | -52.3% | -51.1% | -27.8% | |
| Income taxes | 0.1% | 0.1% | 0.1% | 0.1% | |
| Net income | -66.9% | -52.4% | -59.4% | 0.0% | |
|